Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10008450HBVENSG00000175344.19protein_codingCHRNA7NoNo1139P36544
TVIS10034714HBVENSG00000175344.19protein_codingCHRNA7NoNo1139P36544
TVIS20027526HPVENSG00000175344.19protein_codingCHRNA7NoNo1139P36544
TVIS44009999HTLV-1ENSG00000175344.19protein_codingCHRNA7NoNo1139P36544
TVIS44012786HTLV-1ENSG00000175344.19protein_codingCHRNA7NoNo1139P36544
TVIS44033742HTLV-1ENSG00000175344.19protein_codingCHRNA7NoNo1139P36544
TVIS44000630HTLV-1ENSG00000175344.19protein_codingCHRNA7NoNo1139P36544
TCGA Plot Options
Drug Information
GeneCHRNA7
DrugBank IDDB01273
Drug NameVarenicline
Target IDBE0002341
UniProt IDP36544
Regulation Typeagonist
PubMed IDs16766716
CitationsMihalak KB, Carroll FI, Luetje CW: Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Mol Pharmacol. 2006 Sep;70(3):801-5. Epub 2006 Jun 9.
GroupsApproved; Investigational
Direct Classification
SMILESC1C2CNCC1C1=C2C=C2N=CC=NC2=C1
Pathways
PharmGKBPA164781343
ChEMBLCHEMBL1396